The White House on Friday said Novo Nordisk's weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have to ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNFA" or the "Company"), a clinical stage biopharmaceutical company committed to ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

Investing.com -- Shares of Novo Nordisk (NYSE: NVO) fell 2% following the announcement of results from its STEP UP obesity trial, which showed that Semaglutide 7.2 mg achieved a 20.7% weight loss in ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...